Enhancing the selective tumor cell-killing effects of purine synthesis inhibitors in mTORC1-driven tumors
Principal Investigator: Alexander Valvezan
Affiliation: Center for Advanced Biotechnology & Medicine
Amount: $100,000
Sponsor: Princeton University